rhCMV-based vector vaccine program (Virogenomics)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerhCMV-based vector vaccine program (Virogenomics)
Drug Alias Namerecombinant human CMV-based vector vaccine program (Virogenomics)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCluster of differentiation 8 stimulantsT-cell surface antigen CD4 agonists
TargetsCluster of differentiation 8T-cell surface antigen CD4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirogenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirogenomics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A